News
The Milan Cell and Gene Center of Excellence at AGC Biologics will produce LVV material for Treg cell therapy candidates.
Research highlights the potential risks of antiepileptic drugs during pregnancy, including teratogenicity and ...
AI is increasingly being adopted by sponsors for various applications in clinical trials, including optimising trial design, ...
Greeks remain 'spectators' to pharmaceutical innovation. New medicines are frequently approved, but never reach patients.
Greeks remain 'spectators' to pharmaceutical innovation. New medicines are frequently approved, but never reach patients.
A recent study reveals that the average duration of ADHD medication for children and adolescents is more than three years. However, reliable, controlled data on the safety of marketed ADHD medicines ...
Shares of the biotech fell around 15% on news the FDA is not only taking longer to review the drug, but will assemble an ...
The U.S. Food and Drug Administration has issued a warning about a popular pain medication for dogs that's prescribed by veterinarians.
BEIJING, CN / ACCESS Newswire / May 16, 2025 / CASI Pharmaceuticals, Inc. (NASDAQ:CASI), ("CASI" or the "Company"), a Cayman incorporated biopharmaceutical company focused on developing and ...
The approval marks the second international approval for rozanolixizumab (Rystiggo; UCB Pharma) for generalized myasthenia ...
SHELTON, CT / ACCESS Newswire / May 16, 2025 / NanoViricides, Inc. (NYSE Amer.:NNVC) (the "Company"), reports that it has filed its Quarterly Report on Form 10-Q for the quarter ending March 31, 2025 ...
NEW YORK, May 15, 2025 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results